1. 1. Issa MM, Fenter TC, Black L, Grogg AL, Kruep EJ. An assessment of the diagnosed prevalence of diseases in men 50 years of age or older. Am J Manag Care 2006;12(Suppl 4):S83-89.
2. 2. Walsh PC, Campbell MF, Retik AB. Study guide Campbell's urology. 8th ed. W.B. Saunders, Philadelphia, 2002, pp 1297-1336.
3. The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A systematic review and meta-analysis;Lee;Sci Rep,2017
4. 4. Fitzpatrick JM. The natural history of benign prostatic hyperplasia. BJU Int 2006;97(Suppl 2):3-6; discussion 21-2.
5. 5. Gravas S, Cornu JN, Gacci M, Gratzke C, Herrmann TRW, Mamoulakis C, Rieken M, Speakman MJ, Tikkinen KAO, Guidelines Associates: Karavitakis M, Kyriazis I, Malde S, Sakalis V. Guidelines Office: Schouten N, Smith EJ. EAU Guidelines on Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). In: EAU Guidelines. 2021 ed. Arnhem, The Netherlands: EAU Guidelines Office; 2021. pp.1-82.